Clinical Trial Update: L Reuteri for the Prevention of Nosocomial Diarrhea [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Lactobacillus reuteri to prevent nosocomial diarrhea has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diarrhea
• Gastroenteritis

Drugs mentioned

• Lactobacillus reuteri (Lactobacillus reuteri)

Snippet

Sponsor: Medical University of Warsaw | Conditions: Nosocomial Infection, Diarrhea | Phase 3 | Status: COMPLETED